课题基金 / 基金详情

EFFECT OF TARGETED LOW DOSE RADIATION TREATMENT ON TUMOR OXYGENATION

EFFECT OF TARGETED LOW DOSE RADIATION TREATMENT ON TUMOR OXYGENATION
靶向低剂量放射治疗对肿瘤氧合的影响
批准号:
6206520
负责人:
ROSALYN D BLUMENTHAL
金额:
$1.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2000-08-31

项目摘要

项目成果

ROSALYN D BLUMENTHAL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term purpose of this research is to determine the feasibility of using in vivo EPR to assess radiation does in accidental exposures to radiation. The current research focuses on the feasibility of using low frequency (L-band) EPR spectroscopy for the measurement of long-lived radiation-induced EPR signals in the teeth of living rats and to compare this with similar measurements in isolated human teeth. The radiation-induced EPR signal in teeth has distinctive characteristics based on its shape and power saturation. The use of teeth also has the advantage of providing a site where very good geometry with a sensitive resonator can readily be achieved for entirely non-invasive measurements in vivo. These results suggest that it may be possible to develop techniques and instruments that will allow these measurements eventually to be made non-invasively in humans. We now have completed the initial measurements of radiation-induced signals from the teeth of living rats and isolated human teeth. Initially the signal intensity from rat teeth which received X-ray radiation was quite weak due to its very small size and weight (about 100mg), so while it was detectable with X-band EPR, very high doses were needed to observe it with L-band. We therefore made a new loop resonator specially designed for rat teeth and this increased the sensitivity to a useful level. We also used the new resonator to obtain data from isolated human teeth with a present limit of detection of about 1Gy. Further technical developments should extend this to even lower doses. We conclude that human in vivo EPR dosimetry will be feasible.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Animal Studies
Chronobiological Principles to Maximize Efficacy of Alt*
PRE-CLINICAL COMBINATION CHEMO- AND RADIOANTIBODY THERAP
PRE-CLINICAL COMBINATION CHEMO/RADIOANTIBODY THERAPY
海外基金